Navigation Links
Phenylketonuria in Medical News

Patents Issued Covering Stable Tablet Formulation and Once Daily Dosing Regimen for Kuvan

... dihydrochloride) for the treatment of phenylketonuria (PKU). The patent for stable tablet formulation ... due to tetrahydrobiopterin- (BH4-) responsive phenylketonuria (PKU). Kuvan is to be used in conjunction with a ... )(sapropterin dihydrochloride) Tablets, for phenylketonuria (PKU), developed in partnership with Merck ...

BioMarin Receives 2009 Corporate Award for the Development of Kuvan

... toward improving the lives of people living with phenylketonuria (PKU). NORD honored BioMarin for the ... due to tetrahydrobiopterin- (BH4-) responsive phenylketonuria (PKU). PKU is a rare genetic disorder that can ... Tablets, a product for the treatment of phenylketonuria (PKU), developed in partnership with Merck ...

JCI online early table of contents: July 1, 2008

... Bringing stability to the protein defective in phenylketonuria phenylketonuria (PKU) is an inherited disease characterized by ... as potential therapeutic agents to treat phenylketonuria AUTHOR CONTACT: Aurora Martinez University ...

BioMarin Announces Second Quarter 2009 Financial Results

... (sapropterin dihydrochloride) Tablets, a product for the treatment of phenylketonuria (PKU), was $16.9 million for the second quarter of 2009, compared to $12.0 ... Corporation; and Kuvan(R) (sapropterin dihydrochloride) Tablets, for phenylketonuria (PKU), developed in partnership with Merck Serono, a division of Merck ...

Results From Phase 1 Clinical Study of PEG-PAL in PKU and Update on Phase 2 Clinical Study

... (PEGylated recombinant phenylalanine ammonia lyase) for the treatment of phenylketonuria (PKU). The company expects to initiate the Phase 2 clinical study in late ... Corporation; and Kuvan(R) (sapropterin dihydrochloride) Tablets, for phenylketonuria (PKU), developed in partnership with Merck Serono, a division of Merck ...

The National PKU Alliance Expands Leadership and Names Christine Brown as Executive Director

... dedicated to supporting those affected by the genetic disorder phenylketonuria (PKU), today announced that it has selected Christine Brown to be its ... Violence Coordinating Council in Maryland. About PKU PKU, or phenylketonuria (pronounced fen-il-Key-to-New-ree-uh ) is a lifelong genetic disorder in ...

Fairview Specialty Pharmacy Signs Contract With BioMarin for Distribution of Kuvan(TM)

... Tablets, the first specific drug therapy approved for the treatment of phenylketonuria (PKU). Kuvan was approved by the U.S. Food and Drug Administration (FDA) ... hyperphenylalaninemia (HPA) due to tetrahydrobiopterin- (BH4-) responsive phenylketonuria (PKU). Kuvan is to be used in conjunction with a Phe-restricted diet. ...

BioMarin Re-Acquires Rights to Kuvan in Canada From Merck Serono

... Darmstadt, Germany. Kuvan is an oral small molecule for the treatment of phenylketonuria (PKU) developed in partnership with Merck Serono. Based on published ... hyperphenylalaninemia (HPA) due to tetrahydrobiopterin- (BH4-) responsive phenylketonuria (PKU). Kuvan is to be used in conjunction with a Phe-restricted diet. ...

Meta-Analysis of Blood Phe Levels and Clinical Outcomes in PKU Published

... meta-analysis of blood phenylalanine (Phe) levels and clinical outcomes in phenylketonuria (PKU) was published in the September/October 2007 issue of Molecular ... dihydrochloride), a Phase 3 product candidate for the treatment of phenylketonuria (PKU), and 6R-BH4 for cardiovascular indications, which is currently in ...

Patient Enrollment Complete for Phase I/II Clinical Trial for GALNS for Morquio A Syndrome

... developed through a 50/50 joint venture with Genzyme Corporation; and Kuvan(R) (sapropterin dihydrochloride) Tablets, a product for the treatment of phenylketonuria (PKU), developed in partnership with Merck Serono, a division of Merck KGaA of Darmstadt, Germany. Other product candidates include PEG-PAL ...
Phenylketonuria in Medical Technology

BioMarin Announces FDA Approval for Kuvan

... Tablets, the first specific drug therapy approved for the treatment of phenylketonuria (PKU). Shipments to the distribution channel will commence tomorrow, and ... hyperphenylalaninemia (HPA) due to tetrahydrobiopterin- (BH4-) responsive phenylketonuria (PKU). Kuvan is to be used in conjunction with a Phe-restricted diet. ...

Positive Kuvan(TM) Pivotal Phase 3 Trial Results Published in The Lancet

... with Kuvan results in significant reductions in blood Phe levels in some phenylketonuria (PKU) patients. Kuvan, an investigational oral small molecule for the ... dihydrochloride), a Phase 3 product candidate for the treatment of phenylketonuria (PKU), and 6R-BH4 for cardiovascular indications, which is currently in ...

BioMarin Initiates Phase 1/2 Clinical Trial for GALNS for Morquio A Syndrome

... developed through a 50/50 joint venture with Genzyme Corporation; and Kuvan(R) (sapropterin dihydrochloride) Tablets, a product for the treatment of phenylketonuria (PKU), developed in partnership with Merck Serono, a division of Merck KGaA of Darmstadt, Germany. Other product candidates include PEG-PAL ...

BioMarin Partner AnGes MG, Inc. Submits BLA to Japanese Ministry of Health

... Corporation. Investigational product candidates include Kuvan(TM) (sapropterin dihydrochloride), a Phase 3 product candidate for the treatment of phenylketonuria (PKU), and 6R-BH4 for cardiovascular indications, which is currently in Phase 2 clinical development for the treatment of peripheral arterial disease ...
Phenylketonuria in Medical Definition

Pathology

... - Hypervitaminosis D v • d • e Metabolic pathology ( E70-90 , 270-279 ) Amino acid Aromatic ( phenylketonuria , Alkaptonuria , Ochronosis , Tyrosinemia , Albinism , Histidinemia ) - Branched chain ( Maple syrup urine disease , Propionic acidemia , ...
Phenylketonuria in Medical Dictionary

Phenylalanine

... make the protein s that form human tissue s. phenylketonuria ( PKU ) ... 6. D- phenylalanine derivatives ... people that have a rare genetic order called phenylketonuria , also known as PKU . - L-dopa (L-dihydroxy ... One of the best known examples of this is phenylketonuria ( PKU ). This is an genetic error in ...

Phenylketonuria

... phenylketonuria ( PKU ) is inherited as an autosomal recessive ... gene for the child to be affected). phenylketonuria is a type of birth defect a child inherits ... parents, who pass along the abnormal gene . phenylketonuria , maternal: See Maternal ...

Pku

... PKU : Short for phenylketonuria . See: phenylketonuria . Search All of MedicineNet For: search help Printer-Friendly Format ... More on Pku phenylketonuria - inherited metabolic disorder caused by the ...

Circumcision

... Bottle- Feeding , Breast-Feeding , Circumcision , Crying , Age 3 and Younger, Immunizations , Jaundice in Newborns (Hyperbilirubinemia), phenylketonuria ( PKU ), Rash , Age 11 and Younger, Scalp Problems, Shaken Baby Syndrome , ... Ciliary Body Cimetidine (H2 Receptor Antagonists) Cinfacrom ...

Drug

... Drug Administration (FDA) to be safe for use by almost all people. The exception is for those very rare people who are born with a condition called phenylketonuria ( PKU ). Allergic vasculitis is hypersensitivity to a drug or foreign agent that leads to inflammation and damage to blood vessels of the ...

Encephalitis

... nausea , vomiting , and nervous system problems. Several types of opportunistic infections can cause encephalitis . encephalitis untreated phenylketonuria The severity of the condition varies between individuals, ranging from the most severe (extremely unusual, repetitive, self- injurious, and ...

Fetus

... fetus has an increased risk for developing a congenital heart defect when the mother has one of the following medical conditions: 4 Diabetes phenylketonuria (back to top) ... If fetus mature, consider delivery for fetal indications. If immature, repeat BPP within 24 hours 6/10 abnormal AFV High ...

Galactose

... weeks of age. The most common newborn screening tests in the U.S. include those for hypothyroidism (underactivity of the thyroid gland ) , PKU ( phenylketonuria ), galactose mia , ... ...

Galactosemia

... defect, to what Garrod called an "inborn error of metabolism ." Today, newborns are routinely screened for certain enzyme defects such as PKU ( phenylketonuria ) and galactosemia , ... Other factors which can potentiate jaundice in the newborn include: sepsis , biliary atresia , Rh incompatibility, ...

Ketones

... including CBC and blood chemistry (chem-20) Urine analysis for ketones and severity of dehydration Pregnancy test s ... untreated phenylketonuria , a problem in the body's ability to handle certain chemicals named phenyl ketones lack of oxygen during birth encephalitis or other serious ...

More>>

Phenylketonuria in Biological News

UW-Madison study reveals new options for people with PKU

... MADISON For people with the genetic condition known as phenylketonuria (PKU), diet is a constant struggle. They can eat virtually no protein, and instead get their daily dose of this key macronutrient by drinking a ...

New drug holds out promise of normal diet for sufferers of devastating PKU genetic disease

... Margie Fischer doesn't have to imagine it; that was normal life at her family's dinner table for years. Her daughter Maggie, now 20, suffers from phenylketonuria (PKU), a genetic disease that means her body can't tolerate anything more than a low-protein diet. PKU is described by scientists as an autosomal ...

Children's Memorial Hospital of Chicago receives a grant from BioMarin to support adult PKU outreach

... IL, Children's Memorial Hospital of Chicago announced today that it has received a grant from BioMarin Pharmaceutical Inc. to support its Adult phenylketonuria (PKU) Outreach Education Project. The goal of the program is to conduct outreach to PKU patients who are no longer being treated at PKU clinics to ...

Nationwide Children's Hospital involved in expanded access program for treatment of PKU

... announced today its involvement in an expanded access program for sapropterin dihydrochloride, or sapropterin, an investigational treatment for phenylketonuria (PKU), a rare genetic metabolic disorder that, if left unmanaged in infants and children, can result in severe mental retardation. Currently, there ...

Birth defects: 8 million annually worldwide

... with genetic disorders; Establish newborn screening programs to identify babies born with devastating but treatable metabolic disorders such as phenylketonuria (PKU); Educate women and men of childbearing age about how they can work with health professionals to maximize the chances of having a healthy ...
Phenylketonuria in Biological Technology

Kuvan Receives Priority Review Status From Health Canada

... as an oral treatment for patients with phenylketonuria (PKU) from Health Canada. Priority review ... due to tetrahydrobiopterin- (BH4-) responsive phenylketonuria (PKU). Kuvan is to be used in conjunction with a ... (sapropterin dihydrochloride) Tablets, for phenylketonuria (PKU), developed in partnership with Merck ...

BioMarin Receives Notice of Allowance for Once Daily Dosing Patent for Kuvan

... (sapropterin dihydrochloride) in the treatment of phenylketonuria (PKU). The company expects that the patent will ... due to tetrahydrobiopterin- (BH4-) responsive phenylketonuria (PKU). Kuvan is to be used in conjunction with a ... Tablets, a product for the treatment of phenylketonuria (PKU), developed in partnership with Merck ...

Kuvan, Naglazyme and Aldurazyme Data to Be Presented at the 57th Annual Meeting of the American Society of Human Genetics

... Phenylalanine (Phe) tolerance in children with phenylketonuria (PKU) maintained on a Phe-restricted diet ... (sapropterin) in children with phenylketonuria (PKU) on a phenylalanine (Phe)-restricted diet ... treatment over 22 weeks in patients with phenylketonuria (PKU) (Randolph) -- 2231 -- Dose-related ...

BioMarin Announces First Quarter 2009 Financial Results

... (sapropterin dihydrochloride) Tablets, a product for the treatment of phenylketonuria (PKU), was $15.5 million for the first quarter of 2009, compared to $5.8 ... Corporation; and Kuvan(R) (sapropterin dihydrochloride) Tablets, for phenylketonuria (PKU), developed in partnership with Merck Serono, a division of Merck ...

BioMarin Announces Fourth Quarter and Full Year 2008 Financial Results

... (sapropterin dihydrochloride) Tablets, a product for the treatment of phenylketonuria (PKU), was $15.1 million for the fourth quarter of 2008 and $46.7 million ... Corporation; and Kuvan(R) (sapropterin dihydrochloride) Tablets, for phenylketonuria (PKU), developed in partnership with Merck Serono, a division of Merck ...

BioMarin Announces Third Quarter 2008 Financial Results

... (sapropterin dihydrochloride) Tablets, a product for the treatment of phenylketonuria (PKU), was $13.8 million for the third quarter of 2008 and $31.6 million ... Corporation; and Kuvan(R) (sapropterin dihydrochloride) Tablets, for phenylketonuria (PKU), developed in partnership with Merck Serono, a division of Merck ...

Biopten (Sapropterin Dihydrochloride) Approved by Japanese Ministry of Health for the Treatment of PKU

... ingredient as Kuvan(R) in the U.S., for the treatment of patients with phenylketonuria (PKU). BioMarin will receive a milestone payment of $1.5 million for this ... hyperphenylalaninemia (HPA) due to tetrahydrobiopterin- (BH4-) responsive phenylketonuria (PKU). Kuvan is to be used in conjunction with a Phe-restricted diet. ...

Exclusive Rights to Kuvan(TM) Data Licensed to Asubio Pharma in Japan

... Labour and Welfare for approval of its BH4 product for the treatment of phenylketonuria (PKU) in Japan. The application is for a label extension for its current ... dihydrochloride), a Phase 3 product candidate for the treatment of phenylketonuria (PKU), and 6R-BH4 for cardiovascular indications, which is currently in ...

BioMarin to Present at the Jefferies Healthcare Conference

... a product which BioMarin developed through a 50/50 joint venture with Genzyme Corporation; and Kuvan(R) (sapropterin dihydrochloride) Tablets, for phenylketonuria (PKU), developed in partnership with Merck Serono, a division of Merck KGaA of Darmstadt, Germany. Other product candidates include PEG-PAL ...

BioMarin to Present at the Goldman Sachs Healthcare Conference

... a product which BioMarin developed through a 50/50 joint venture with Genzyme Corporation; and Kuvan(R) (sapropterin dihydrochloride) Tablets, for phenylketonuria (PKU), developed in partnership with Merck Serono, a division of Merck KGaA of Darmstadt, Germany. Other product candidates include PEG-PAL ...
Phenylketonuria in Biological Definition

Enzyme

... 2,000 types present in our bodies can lead to severe or lethal illness. An example of a disease caused by an enzyme malfunction in humans is phenylketonuria (PKU). The enzyme phenylalanine hydroxylase , which usually converts the essential amino acid phenylalanine into tyrosine does not work, resulting ...

Guthrie test

... on blood samples taken from the heel of the baby, at or before 4 days of age. The test typically screens for the following diseases: phenylketonuria Hypothyroidism Cystic Fibrosis Galactosemia ...
Other Contents
(Date:9/20/2014)... "As a nurse, patients always ask me how ... from Tamaqua, Pa. "The reason that they cannot tell is ... chairs. My invention enables them to check oxygen levels on ... make it easier to monitor the contents of an oxygen ... tank is low. It allows changeovers to be performed under ...
(Date:9/20/2014)... Los Angeles, CA (PRWEB) September 20, 2014 ... power score of 3.1 out of 5, indicating a ... research firm IBISWorld, this score reflects current and future ... negotiate from historically high prices. Other factors that negatively ... volatility in demand for construction and the moderate switching ...
(Date:9/20/2014)... Wisconsin (PRWEB) September 20, 2014 QueenBeeTickets.com ... the young star’s tour performances. She will visit many ... of February until the 16th of April. , ... Grande Honeymoon Tour tickets at QueenBeeTickets.com. , The star’s ... opportunity to see their favorite young singer in a ...
(Date:9/20/2014)... (PRWEB) September 20, 2014 Final Cut ... announced the release of the Information theme for FCPX filmmakers. ... use to describe the Information theme,” says Christina Austin, CEO ... to look so professional.” , Information features easy to use ... parameters of the environment. Change the background color, color of ...
(Date:9/20/2014)... 2014 The first federal bellwether trial ... its third week in the U.S. District Court, Northern ... documents indicate that the week opened in the ... a DePuy Orthopaedics vice president, who discussed the clinical ... Pinnacle hip replacement. According to Reuters, the executive stated ...
Breaking Medicine News(10 mins):Health News:Plumbing Construction Services Procurement Category Market Research Report from IBISWorld Has Been Updated 2Health News:Plumbing Construction Services Procurement Category Market Research Report from IBISWorld Has Been Updated 3Health News:Plumbing Construction Services Procurement Category Market Research Report from IBISWorld Has Been Updated 4Health News:Discount Ariana Grande Tickets: QueenBeeTickets.com Delights Fans with Discount Concert Tickets for Ariana Grande’s 2015 Honeymoon Tour 2Health News:Today Pixel Film Studios Announced the Release of the Information Theme for Final Cut Pro X 2Health News:Third Week of DePuy Pinnacle Hip Lawsuit Trial Focuses on Clinical Testing of Metal-on-Metal Hip Implant, Wright & Schulte LLC Reports 2Health News:Third Week of DePuy Pinnacle Hip Lawsuit Trial Focuses on Clinical Testing of Metal-on-Metal Hip Implant, Wright & Schulte LLC Reports 3Health News:Third Week of DePuy Pinnacle Hip Lawsuit Trial Focuses on Clinical Testing of Metal-on-Metal Hip Implant, Wright & Schulte LLC Reports 4
(Date:9/19/2014)... study the unique bioelectric signaling system of the electric ... The OU researcher is working to understand how ... signals used to map the world around them. ... 500-600 discharges a second throughout their lives. The ... but necessary for survival. , "There is evidence that ...
(Date:9/19/2014)... , Sept. 19, 2014 Nxt-ID, Inc. (Nasdaq: ... company focused on the growing m-commerce market, updates the "Wocket in ... in the lightweight and light middleweight weight classes, Vinny Pazienza ... was announced that Game of Thrones actor Ciaran ... with Children star Katey Sagal have been cast ...
(Date:9/18/2014)... located deep in the primitive brainstem has revealed how ... Harvard School of Medicine and the University at Buffalo ... the second "sleep node" identified in the mammalian brain ... to produce deep sleep. , Published online in August ... fully half of all of the brain,s sleep-promoting activity ...
Breaking Biology News(10 mins):NXT-ID's Vinny Paz Celebrity Ad Wocket Update: Katey Sagal and Ciaran Hinds Attached to His Upcoming Movie 2NXT-ID's Vinny Paz Celebrity Ad Wocket Update: Katey Sagal and Ciaran Hinds Attached to His Upcoming Movie 3No sedative necessary: Scientists discover new 'sleep node' in the brain 2
Other TagsOther Tags